Latest Breaking News On - சோதனை திட்பநுட்பம் - Page 1 : vimarsana.com

Share this article Share this article FRANKLIN LAKES, N.J., May 13, 2021 /PRNewswire/ BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the industry s first self-collection claim for HPV screening has been CE marked to the IVD directive 98/79/EC. The new claim allows laboratories and facilities to process self-collected samples via a BD diluent tube using the BD Onclarity™ HPV Assay on either the BD Viper™ LT or the BD COR™ System. The BD Viper™ LT is in use globally and the BD COR™ System, launched last year, is in use across Europe. BD Onclarity™ HPV Assay 3-Well PCR Reagent Wells

United statesHologic preservcytJeff andrewsJesper bondeIntraepithelial neoplasiaTroy kirkpatrickClin microbiolKristenm stewartGlobal medical affairsEuropean unionWorld health organizationEuropean union member statesMolecular pathology laboratoryGlobal strategyCervical cancerSenior researcher